2-[(cyanomethyl)sulfanyl]-N-(4-methylphenyl)acetamide

Compound number
MolPort-000-160-629
IUPAC
2-[(cyanomethyl)sulfanyl]-N-(4-methylphenyl)acetamide
IUPAC traditional
2-[(cyanomethyl)sulfanyl]-N-(4-methylphenyl)acetamide
SMILES
Cc1ccc(NC(=O)CSCC#N)cc1
InChI key
NFWVZDLIBRAWKZ-UHFFFAOYSA-N
Molecular formula
Molecular weight
220.29
Solubility
not available

Marketplace Offers

Vitas M Chemical Limited

Direct S&H to USA:
220.00 USD
Catalog
Screening compound
Ships out
15 business days
Purity
>90%
Last updated
this week
In warehouse
15.00 mg

Supplier Catalogue Data

Pack size Ships out Price Quantity
1 mg September 5, 2022 30.22 USD
Add to Cart Buy
2 mg September 5, 2022 31.93 USD
Add to Cart Buy
3 micromol September 5, 2022 30.00 USD
Add to Cart Buy

ChemBridge Corporation

Direct S&H to USA:
45.00 USD
Catalog
Screening compound
Ships out
20 business days
Purity
90%
Last updated
last week
In warehouse
100.00 mg
Salt: FREE

Supplier Catalogue Data

Pack size Ships out Price Quantity
5 micromol September 12, 2022 26.00 USD
Add to Cart Buy
1 mg September 12, 2022 24.00 USD
Add to Cart Buy
5 mg September 12, 2022 29.00 USD
Add to Cart Buy

Get your compounds in the right format

Molport Reweighting and Reformatting Services

More Information

Compound identifiers

Compound number
MolPort-000-160-629

Names, Synonyms and 3rd Party Identifiers

Name
2-[(cyanomethyl)sulfanyl]-N-(4-methylphenyl)acetamide
MFCD04222070

InChI

InChI
1/C11H12N2OS/c1-9-2-4-10(5-3-9)13-11(14)8-15-7-6-12/h2-5H,7-8H2,1H3,(H,13,14)
InChI key
NFWVZDLIBRAWKZ-UHFFFAOYSA-N

Formula

Molecular formula
C11H12N2OS
Molecular weight
220.29

Molport Guarantee

When you purchase products through the Molport website from any seller other than Molport itself, you will be protected by the Molport Guarantee. If you purchase products from Molport itself, this Molport Guarantee will not apply, and your remedies will be governed by the Molport Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback